Publicaciones en colaboración con investigadores/as de Linköping University (8)

2022

  1. Cancer vaccines: the next immunotherapy frontier

    Nature Cancer, Vol. 3, Núm. 8, pp. 911-926

  2. Immune response differs between intralymphatic or subcutaneous administration of GAD-alum in individuals with recent onset type 1 diabetes

    Diabetes/Metabolism Research and Reviews, Vol. 38, Núm. 3

  3. Intra-lymphatic administration of GAD-alum in type 1 diabetes: long-term follow-up and effect of a late booster dose (the DIAGNODE Extension trial)

    Acta Diabetologica, Vol. 59, Núm. 5, pp. 687-696

2020

  1. Glutamic Acid Decarboxylase Injection Into Lymph Nodes: Beta Cell Function and Immune Responses in Recent Onset Type 1 Diabetes Patients

    Frontiers in Immunology, Vol. 11

2018

  1. Intralymphatic Glutamic Acid Decarboxylase-Alum Administration Induced Th2-Like-Specific Immunomodulation in Responder Patients: A Pilot Clinical Trial in Type 1 Diabetes

    Journal of Diabetes Research, Vol. 2018

  2. Serum miRNA levels are related to glucose homeostasis and islet autoantibodies in children with high risk for type 1 diabetes

    PLoS ONE, Vol. 13, Núm. 1

2017

  1. Effect of simultaneous vaccination with H1N1 and GAD-alum on GAD65-induced immune response

    Diabetologia, Vol. 60, Núm. 7, pp. 1276-1283

  2. More on Intralymphatic injection of Autoantigen in Type 1 Diabetes

    New England Journal of Medicine